TG and thyroid gland disorder: A prospective study of 26 patients with malignant diseases who received ICPi demonstrated an early significant increase (≤4 weeks) in the serum Tg levels and thyroid autoantibodies, anti-TgAbs and anti-TPOAbs, in the ir thyroid disorders group compared to the no ir thyroid disorders group (p < 0.05) [98].